Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Cancer
|
January 26, 2011
Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group
Suman Malempati, David A Rodeberg, Sarah S Donaldson, et al.
Journal of Pediatric Surgery
|
November 11, 2024
How Many Lymph Nodes are Enough in Paratesticular Rhabdomyosarcoma?
Katelyn A Spencer, Brittany Levy, Will Cranford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 20, 2015
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group
Suzanne L Wolden, Elizabeth R Lyden, Carola A Arndt, et al.
Pediatric Blood & Cancer
|
February 1, 2021
Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Timothy N Rogers, Guido Seitz, Jörg Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group
David A Rodeberg, Julie A Stoner, Andrea Hayes-Jordan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group
Abby R Rosenberg, James R Anderson, Elizabeth Lyden, et al.
Journal of Pediatric Surgery
|
October 28, 2020
Lymphadenopathy in children: A streamlined approach for the surgeon - A report from the APSA Cancer Committee
Christa N Grant, Jennifer Aldrink, Timothy B Lautz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 23, 2011
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study
John Breneman, Jane Meza, Sarah S Donaldson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2015
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Brenda J Weigel, Elizabeth Lyden, James R Anderson, et al.
Journal of Pediatric Surgery
|
March 13, 2003
Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997
Martin L Blakely, Richard J Andrassy, R Beverly Raney, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Cancer
|
January 26, 2011
Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group
Suman Malempati, David A Rodeberg, Sarah S Donaldson, et al.
Journal of Pediatric Surgery
|
November 11, 2024
How Many Lymph Nodes are Enough in Paratesticular Rhabdomyosarcoma?
Katelyn A Spencer, Brittany Levy, Will Cranford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 20, 2015
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group
Suzanne L Wolden, Elizabeth R Lyden, Carola A Arndt, et al.
Pediatric Blood & Cancer
|
February 1, 2021
Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Timothy N Rogers, Guido Seitz, Jörg Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group
David A Rodeberg, Julie A Stoner, Andrea Hayes-Jordan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group
Abby R Rosenberg, James R Anderson, Elizabeth Lyden, et al.
Journal of Pediatric Surgery
|
October 28, 2020
Lymphadenopathy in children: A streamlined approach for the surgeon - A report from the APSA Cancer Committee
Christa N Grant, Jennifer Aldrink, Timothy B Lautz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 23, 2011
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study
John Breneman, Jane Meza, Sarah S Donaldson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2015
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Brenda J Weigel, Elizabeth Lyden, James R Anderson, et al.
Journal of Pediatric Surgery
|
March 13, 2003
Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997
Martin L Blakely, Richard J Andrassy, R Beverly Raney, et al.
Page
of 7